These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 25931584)

  • 1. A systematic review of transfusion-associated graft-versus-host disease.
    Kopolovic I; Ostro J; Tsubota H; Lin Y; Cserti-Gazdewich CM; Messner HA; Keir AK; DenHollander N; Dzik WS; Callum J
    Blood; 2015 Jul; 126(3):406-14. PubMed ID: 25931584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How is transfusion-associated graft-versus-host disease similar to, yet different from, organ transplantation-associated graft-versus-host disease?
    Sato N; Marubashi S
    Transfus Apher Sci; 2022 Apr; 61(2):103406. PubMed ID: 35283033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA homozygosity and shared HLA haplotypes in the development of transfusion-associated graft-versus-host disease.
    Shivdasani RA; Anderson KC
    Leuk Lymphoma; 1994 Oct; 15(3-4):227-34. PubMed ID: 7866271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential for transfusion-associated graft-versus-host disease due to apheresis platelets matched for HLA class I antigens.
    Grishaber JE; Birney SM; Strauss RG
    Transfusion; 1993; 33(11):910-4. PubMed ID: 8259596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transfusion-associated graft-versus-host disease and the irradiation of blood components.
    Davey RJ
    Immunol Invest; 1995; 24(1-2):431-4. PubMed ID: 7713602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of universal leukodepletion of the blood supply on hemovigilance reports of posttransfusion purpura and transfusion-associated graft-versus-host disease.
    Williamson LM; Stainsby D; Jones H; Love E; Chapman CE; Navarrete C; Lucas G; Beatty C; Casbard A; Cohen H
    Transfusion; 2007 Aug; 47(8):1455-67. PubMed ID: 17655590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [One-way matching of HLA antigens between recipient and donor as a risk factor of transfusion-associated GVHD].
    Takahashi K
    Nihon Rinsho; 1997 Sep; 55(9):2240-5. PubMed ID: 9301283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transfusion-associated graft-versus-host disease in a liver transplant recipient: an unusual presentation and review of the literature.
    O'Brien KL; Pereira SE; Wagner J; Shadman M; Hendrie P; Nelson K; Gernsheimer TB; Price T; Reyes JD; Nester T
    Transfusion; 2013 Jan; 53(1):174-80. PubMed ID: 22563807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transfusion-associated graft-versus-host disease in an immunocompetent patient following cardiac surgery.
    Rososhansky S; Badonnel MC; Hiestand LL; Popovsky MA; Szymanski IO
    Vox Sang; 1999; 76(1):59-63. PubMed ID: 9933856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transfusion-associated graft-versus-host disease reexamined: potential for improved prevention using a universally applied intervention.
    Kleinman S; Stassinopoulos A
    Transfusion; 2018 Nov; 58(11):2545-2563. PubMed ID: 30267423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transfusion associated graft versus host disease in an immunocompetent individual following coronary artery bypass grafting.
    Ahya R; Douglas JG; Watson HG
    Heart; 1998 Sep; 80(3):299-300. PubMed ID: 9875094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Transfusion-associated graft-versus-host disease].
    Bojanić I; Cepulić BG
    Lijec Vjesn; 2004; 126(1-2):39-47. PubMed ID: 15526751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transfusion-associated graft-versus-host disease in immunocompetent patients: report of a fatal case associated with transfusion of blood from a second-degree relative, and a survey of predisposing factors.
    Petz LD; Calhoun L; Yam P; Cecka M; Schiller G; Faitlowicz AR; Herron R; Sayah D; Wallace RB; Belldegrun A
    Transfusion; 1993 Sep; 33(9):742-50. PubMed ID: 8105567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transfusion-associated graft vs. host disease after donor-specific leukocyte transfusion before kidney transplantation.
    van der Mast BJ; van den Dorpel MA; Drabbels JJ; Claas FH; Weimar W
    Clin Transplant; 2003 Oct; 17(5):477-83. PubMed ID: 14703935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fatal transfusion-associated graft-versus-host disease with concomitant immune hemolysis in a group A combat trauma patient resuscitated with group O fresh whole blood.
    Gilstad C; Roschewski M; Wells J; Delmas A; Lackey J; Uribe P; Popa C; Jardeleza T; Roop S
    Transfusion; 2012 May; 52(5):930-5. PubMed ID: 21981662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Universal or selective irradiation: a comparison of approaches.
    Satake M; Suto Y
    Transfus Apher Sci; 2022 Apr; 61(2):103403. PubMed ID: 35283032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of transfusion-associated graft-versus-host disease.
    Yasuda H; Ohto H; Abe R
    Fukushima J Med Sci; 1993 Dec; 39(2):69-75. PubMed ID: 7927137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guideline development for prevention of transfusion-associated graft-versus-host disease: reduction of indications for irradiated blood components after prestorage leukodepletion of blood components.
    Wiersum-Osselton JC; Slomp J; Frederik Falkenburg JH; Geltink T; van Duijnhoven HLP; Netelenbos T; Schipperus MR
    Br J Haematol; 2021 Dec; 195(5):681-688. PubMed ID: 34490619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of 66 patients definitive with transfusion-associated graft-versus-host disease and the effect of universal irradiation of blood.
    Uchida S; Tadokoro K; Takahashi M; Yahagi H; Satake M; Juji T
    Transfus Med; 2013 Dec; 23(6):416-22. PubMed ID: 24274074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transfusion-associated graft-versus-host disease in immunocompetent patients: a self-protective mechanism.
    van der Mast BJ; Hornstra N; Ruigrok MB; Claas FH; van Rood JJ; Lagaaij EL
    Lancet; 1994 Mar; 343(8900):753-7. PubMed ID: 7907730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.